Compounds and methods for downregulating the effects of TGF-beta

Details for Australian Patent Application No. 2004257367 (hide)

Owner Resverlogix, Inc.

Inventors Mihara, Koichiro; Wong, Norman C. W.; Tucker, Joe; Lebioda, Kenneth

Agent Wrays

Pub. Number AU-A-2004257367

PCT Pub. Number WO2005/007199

Priority 60/487,659 16.07.03 US

Filing date 15 July 2004

Wipo publication date 27 January 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/007199 Priority application(s): WO2005/007199

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257373-Lipid encapsulated interfering RNA

2004257363-Subunit vaccine against respiratory syncytial virus infection